Changchun Bcht Biotechnology Co. (WANINAFTRERYYA DAYA [BCHT "ko [Kamfanin") Masana'antu ne na Bipharmaceuthicate da aka ja da kai ga rigakafin da kuma kula da cututtukan cututtuka. Tun da kafa ta 2004, BCSCT ya shiga bincike da ci gaba, masana'antu da rarraba allurai don amfanin ɗan adam. Ta hanyar shekaru na ci gaba, BCSCT ya kafa cikakken tsarin aiki a kusa da samfuran rayuwa, wanda aka aiwatar da kayan sarrafawa a cikin dukkanin kayan samfuran, aikinku na R & D, Circulation Properation, Ingantaccen sarrafawa da ingancin sarrafawa. Duk hanyoyin haɗin suna da matakan gudanarwa da tsarin kula da ciki. BCHT yanzu yana mallakar shafukan masana'antu uku waɗanda suka rufe murabba'in murabba'in 225,700 a jimla. Dogara a kan fasaharta ta R & D da karfin masana'antu, BCHT ya kafa tsarin kasuwanci, babban kayan aikin kasa da kuma girmamawa. A cikin 2018, 2019 da 2020, kudaden shiga shekara ne daga babban kasuwancin kamfanin shi ne RMB 1.01 biliyan 970, RMB 970 miliyan da RMB 1.44 biliyan bi da bi. A watan Yuni 2021, kamfanin ya sanya a farkon hadayar jama'a da fasaha (kasuwar tauraro), tare da jimlar babban birnin 412,860,698 da kuma farashin hannun jari na 36.35 ya raba. Yawan hannun jari da aka bayar don lissafa 10% na jimlar babban birnin bayan wannan bayarwa, da jimlar kudaden da aka tashe shi kusan Yuan biliyan ne game da biliyan biliyan biliyan 1.5. An ba BCHT a matsayin babban kamfanin kimiyyar Jilin da kuma sauran sassan Jilin, da kuma Cibiyar Alurar da aka yi don fasahar ta zamani, Cibiyar Bincike na Jilin a Cibiyar Kula da Kasuwanci na Kasuwanci, kuma Sanya kamar yadda Kimiyya ta Jilin da fasahar Fasaha, Lardin AAA masu amfani da masana'antu, kasuwancin Changchun Manyan kamfanoni 100 da kamfanoni masu zaman kansu. A shekara ta 2018, BCCT ya lashe lambobin 3.15 da suka fi fifita kayan aikin Sinanci. BCHT yana da ma'aikata 1,049, 571 tare da Digiri na Bachelor ko sama. Daga gare su, akwai ma'aikata 117 R & D 117 R & D 117 R & D, 712 samarwa da kuma Ma'aikata masu inganci, da kuma tallace-tallace 152 da gudanarwa. Kamfanin yana ɗaukar ingancin samfuri azaman tushe, yana ɗaukar ƙirar samfuri da R & D kamar yadda tushen ci gaba, kuma ya ƙaddamar da tsarin gaba don ci gaba mai cikakken ci gaba. Tsarin kayan aikin kamfani mai zaman kanta mai zaman kanta, maganin gargajiya, ana samun nasarar lalata alurar riga kafi a 2008. Shine ne farkon alurar rigakafi na gida, wanda ya rage abubuwan da suka dace da halayen mara kyau. Yana da uciyar farko ta al'ada tare da lokacin inganci na watanni 36 a duniya da kuma kwanciyar hankali a tsakanin samfuran iri ɗaya. Kasancewar kasuwa ta kasance na farko a kasar Sin na shekaru masu yawa. Tsarin kayan aikin kamfani mai zaman kanta mai zaman kanta, maganin gargajiya, ana samun nasarar lalata alurar riga kafi a 2008. Shine ne farkon alurar rigakafi na gida, wanda ya rage abubuwan da suka dace da halayen mara kyau. Yana da uciyar farko ta al'ada tare da lokacin inganci na watanni 36 a duniya da kuma kwanciyar hankali a tsakanin samfuran iri ɗaya. Kasancewar kasuwa ta kasance na farko a kasar Sin na shekaru masu yawa. Kamfanin yana ba da mahimmanci ga Gabatarwa da aikin talanti mafi ƙaranci. A halin yanzu, Digiri na Bachelory ko Asusun Sama da sama da 50% na adadin ma'aikatan, tare da gwani guda 3 (matakin farko) a cikin Jilin Lardin da yawa daga kasashen waje masu zuwa. Kungiyar BchT da yawa ta jagoranci masu fasaha, BCSCT ta kafa kwararru, amintattu da gogaggen kungiyar R & D. Tun da kafuwarsa, an himmatu ga R & D da Masana'antu na allurar rigakafin kwayoyin halitta da magungunan nazarin halittu. At present, there are three approved vaccine products: varicella vaccine, rabies vaccine and influenza vaccine, live, nasal, freeze-dried. A halin yanzu, BCHT yana da allurar rigakafi 14 a cikin bincike na ɗan adam na magungunan cututtukan cututtukan cututtukan ƙwayar cuta, da aka haɗa da rigakafin cututtukan cututtukan fata B na Conjugate, cikakken ɗan adam righten Zabi na Rabies Monoclonal antifin, cikakken ɗan adam Tetanus Toxin Monoconal antibody, da sauransu.